Gary Gershony

Colleagues at BayMed Venture Partners

AW

Amanda White

Senior Associate at BayMed Venture Partners

GG

Gary Gershony, MD

Founding General Partner at BayMed Venture Partners

GW

Gregg W. Stone, MD

Advisor and clinical key opinion leader at BayMed Venture Partners

LS

Leslie Saxon, MD

Advisor and digital health key opinion leader at BayMed Venture Partners

MT

Martin T. Rothman, MD

Advisor and industry key opinion leader at BayMed Venture Partners

NM

Neil Meyer

Founding General Partner at BayMed Venture Partners

Frequently asked questions

Who is Gary Gershony?

Dr. Gary Gershony is an interventional cardiologist who trained at the University of Toronto Medical School and completed a fellowship at Emory University; he has practiced at John Muir Health Cardiovascular Institute since 1999 and previously directed interventional cardiology at UC Davis from 1993 to 1997. He founded Vascular Solutions, which had an IPO in 2000, and co-founded AngioScore, acquired by Spectranetics in 2014, and holds 11 issued medical device patents. He is a founding General Partner of BayMed Venture Partners, a San Francisco venture capital firm focused on early-stage medical device and digital health companies in North America and Israel, and serves on the boards or advisory boards of several medical device companies.

Where does Gary Gershony work?

Gary Gershony is Founding General Partner at BayMed Venture Partners and Board director at Valfixmed.

Where did Gary Gershony go to school?

Gary Gershony studied at Stanford University Graduate School of Business (FANFE - Executive Program); Emory University School of Medicine (Interventional Cardiology Fellowship); University of Toronto (General Cardiology Fellowship).